Analystreport

Regulus Therapeutics Inc. (NASDAQ: RGLS) had its price target lowered by analysts at HC Wainwright from $20.00 to $9.00.

Regulus Therapeutics Inc.  (RGLS) 
Last regulus therapeutics inc. earnings: 3/12 04:37 pm Check Earnings Report
US:NASDAQ Investor Relations: regulusrx.com/investors